Pie Funds Management has added US drugmaker Eli Lilly to its investment portfolio as investors weigh up who’s going to win the battle over obesity drugs.
The local fund manager, with about $2.54 billion under management, added the pharmaceutical company to its KiwiSaver funds and global growth 2 and conservative funds in December, saying it’s well positioned in the global obesity market.
Sin...
